FDA approves aortic securement system for TAAs

Editorial Staff | | Health Imaging | Diagnostic Imaging
The FDA has granted 510(k) clearance for the thoracic-length HeliFX aortic securement system, an updated system to the one cleared in November 2011 to treat abdominal aortic aneurysms. The new system from Aptus Endosystems has a longer delivery device with additional tip configurations to bring the helical EndoAnchor technology to the treatment of thoracic aortic aneurysms (TAA).

The implantable EndoAnchor enables endograft fixation, and is designed to replicate the sealing and fixation of hand suturing performed during open surgical repair of aortic aneurysms, Sunnyvale, Calif.-based Aptus said in a press release. It can be used during de novo thoracic endovascular aortic repair procedures. In addition, the EndoAnchors can be used to repair endovascular grafts that have migrated away from the implant site and have developed endoleaks. 

Clearance of this HeliFX System in the U.S. allows the device to be used with Cook Medical’s Zenith TX2, W.L. Gore’s Tag and Medtronic’s Talent Thoracic and Valiant endografts in both initial implant and secondary repair settings, according to the company. Use with other endografts has not been evaluated to date.

Editorial Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.